Frontiers | Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going?
B cell depletion therapies in autoimmune disease: advances and mechanistic insights | Nature Reviews Drug Discovery
Wirkungsweise von Krebsmedikament entschlüsselt — Hochschul- und Wissenschaftskommunikation
Structure of CD20 in complex with the therapeutic monoclonal antibody rituximab | Science
CD20 — Wikipédia
Expression of CD20 after viral reactivation renders HIV-reservoir cells susceptible to Rituximab | Nature Communications
Expression of CD19 and CD20 according to maturation steps. CD19 is... | Download Scientific Diagram
CD 20 Years Roton Music - Palatul Vechiturilor
Anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia: from uncertainties to promises | Immunotherapy
The applications of anti-CD20 antibodies to treat various B cells disorders - ScienceDirect
CD20 - Wikipedia
SciELO - Brasil - CD20 role in pathophysiology of Hodgkin's disease CD20 role in pathophysiology of Hodgkin's disease
The regulation and function of CD20: an “enigma” of B-cell biology and targeted therapy | Haematologica
Structure of CD20 in complex with the therapeutic monoclonal antibody rituximab | Science
Rituximab, an Anti‐CD20 Monoclonal Antibody: History and Mechanism of Action - Pescovitz - 2006 - American Journal of Transplantation - Wiley Online Library
Ofatumumab - Anwendung, Wirkung, Nebenwirkungen | Gelbe Liste
Frontiers | Anti-CD20 B Cell Treatment for Relapsing Multiple Sclerosis
Anti-CD20 Antibody Therapy for B-Cell Lymphomas | NEJM
Overcoming rituximab drug-resistance by the genetically engineered anti-CD20-hIFN-α fusion protein: Direct cytotoxicity and synergy with chemotherapy
Development of Anti-CD20 Antigen-Targeting Therapies for B-cell Lymphoproliferative Malignancies - The State of the Art | Bentham Science